CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 79 filers reported holding CARDIFF ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 3.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $22,200 | -58.4% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q1 2024 | $53,400 | +140.5% | 10,000 | -33.3% | 0.01% | +100.0% |
| Q4 2023 | $22,200 | +6.5% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $20,850 | -5.4% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $22,050 | -10.9% | 15,000 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $24,750 | +17.9% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $21,000 | -8.7% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $23,000 | -30.3% | 15,000 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $33,000 | -10.8% | 15,000 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $37,000 | -58.9% | 15,000 | 0.0% | 0.01% | -58.8% |
| Q4 2021 | $90,000 | -10.0% | 15,000 | 0.0% | 0.02% | -15.0% |
| Q3 2021 | $100,000 | -24.8% | 15,000 | -25.0% | 0.02% | -25.9% |
| Q2 2021 | $133,000 | -42.7% | 20,000 | -20.0% | 0.03% | -47.1% |
| Q1 2021 | $232,000 | -48.4% | 25,000 | 0.0% | 0.05% | -50.5% |
| Q4 2020 | $450,000 | +26.8% | 25,000 | 0.0% | 0.10% | +18.4% |
| Q3 2020 | $355,000 | +184.0% | 25,000 | 0.0% | 0.09% | +171.9% |
| Q2 2020 | $125,000 | – | 25,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,845,164 | $26,183,000 | 24.69% |
| Corriente Advisors, LLC | 910,000 | $12,913,000 | 6.55% |
| Opaleye Management Inc. | 1,731,600 | $24,571,000 | 4.80% |
| VR Adviser, LLC | 1,271,985 | $18,049,000 | 3.53% |
| Soleus Capital Management, L.P. | 281,819 | $3,999,000 | 2.12% |
| Blue Rock Advisors, LLC | 106,481 | $1,511,000 | 1.30% |
| ACUTA CAPITAL PARTNERS, LLC | 305,900 | $4,341,000 | 1.18% |
| EAM Investors, LLC | 332,900 | $4,724,000 | 1.12% |
| RA Capital Management | 3,290,000 | $46,685,000 | 0.85% |
| EAM Global Investors LLC | 140,231 | $1,990,000 | 0.73% |